Thanks Oscar;
Off Topic : NTI (i.e. ST-LT hold)
Great presentation. Everything in front of the investors' eyes now to make a wiser decision.
First shipment of device in this December.
Certified to sell in whole Europe and Middle East.
US clinical trial underway.
EV $35m.
Experience management on board and being now publicly listed companies, which will be revenue generated soon plus any raising for future innovation will be easier to fund; believe Neurotech management will not stop until Autism but will bring further innovation for brain/nurvous illness.
IMO, NTI will be well over $60 MC by early next year or even earlier.
